Beyond Tumor Accumulation: Molecularly Targeted and Activatable Photoacoustic Contrast Agents
Photoacoustic imaging (PAI) combines optical absorption with ultrasonic detection and has emerged as a powerful platform for noninvasive molecular imaging. The clinical value of a photoacoustic contrast agent (PACA) is not only determined by tumoral accumulation, but also by whether it can generate sufficient target-...